Night work and prostate cancer risk: results from the EPICAP Study.
Details
Serval ID
serval:BIB_8AE167551E40
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Night work and prostate cancer risk: results from the EPICAP Study.
Journal
Occupational and environmental medicine
ISSN
1470-7926 (Electronic)
ISSN-L
1351-0711
Publication state
Published
Issued date
08/2018
Peer-reviewed
Oui
Volume
75
Number
8
Pages
573-581
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
To investigate the role of night work in prostate cancer based on data from the EPICAP Study.
EPICAP is a French population-based case-control study including 818 incident prostate cancer cases and 875 frequency-matched controls that have been interviewed face to face on several potential risk factors including lifetime occupational history. Detailed information on work schedules for each job (permanent or rotating night work, duration, total number of nights, length of the shift, number of consecutive nights) as well as sleep duration and chronotype, was gathered. Prostate cancer aggressiveness was assessed by Gleason Score.
Night work was not associated with prostate cancer, whatever the aggressiveness of prostate cancer, while we observed an overall increased risk among men with an evening chronotype (OR=1.83, 95% CI 1.05 to 3.19). A long duration of at least 20 years of permanent night work was associated with aggressive prostate cancer (OR=1.76, 95% CI 1.13 to 2.75), even more pronounced in combination with a shift length >10 hours or ≥ 6 consecutive nights (OR=4.64, 95% CI 1.78 to 12.13; OR=2.43, 95% CI 1.32 to 4.47, respectively).
Overall, ever night work, either permanent or rotating, was not associated to prostate cancer. Nevertheless, our results suggest that a long duration of permanent night work in combination with a long shift length or at least six consecutive nights may be associated with prostate cancer, particularly with aggressive prostate cancer. Further studies are needed to confirm those findings.
EPICAP is a French population-based case-control study including 818 incident prostate cancer cases and 875 frequency-matched controls that have been interviewed face to face on several potential risk factors including lifetime occupational history. Detailed information on work schedules for each job (permanent or rotating night work, duration, total number of nights, length of the shift, number of consecutive nights) as well as sleep duration and chronotype, was gathered. Prostate cancer aggressiveness was assessed by Gleason Score.
Night work was not associated with prostate cancer, whatever the aggressiveness of prostate cancer, while we observed an overall increased risk among men with an evening chronotype (OR=1.83, 95% CI 1.05 to 3.19). A long duration of at least 20 years of permanent night work was associated with aggressive prostate cancer (OR=1.76, 95% CI 1.13 to 2.75), even more pronounced in combination with a shift length >10 hours or ≥ 6 consecutive nights (OR=4.64, 95% CI 1.78 to 12.13; OR=2.43, 95% CI 1.32 to 4.47, respectively).
Overall, ever night work, either permanent or rotating, was not associated to prostate cancer. Nevertheless, our results suggest that a long duration of permanent night work in combination with a long shift length or at least six consecutive nights may be associated with prostate cancer, particularly with aggressive prostate cancer. Further studies are needed to confirm those findings.
Keywords
Aged, Case-Control Studies, Circadian Rhythm, Employment, France, Humans, Male, Middle Aged, Neoplasm Grading, Occupational Diseases/etiology, Occupational Exposure/adverse effects, Odds Ratio, Prostatic Neoplasms/etiology, Risk Factors, Severity of Illness Index, Sleep, Surveys and Questionnaires, Time Factors, Work Schedule Tolerance/physiology, Cancer, Epidemiology, Shift Work
Pubmed
Web of science
Open Access
Yes
Create date
04/10/2022 11:01
Last modification date
05/10/2022 5:42